Trial of Dexmethylphenidate (Focalin) ER in ADHD
The efficacy and safety of dexmethylphenidate extended release (d-MPH-ER) was compared to placebo in 97 patients (ages 6-17 years) with attention-deficit/hyperactivity disorder (ADHD) in a multicenter, randomized, double-blind, two-phase study reported from New York State Psychiatric Institute, New...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Pediatric Neurology Briefs Publishers,
2006-07-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The efficacy and safety of dexmethylphenidate extended release (d-MPH-ER) was compared to placebo in 97 patients (ages 6-17 years) with attention-deficit/hyperactivity disorder (ADHD) in a multicenter, randomized, double-blind, two-phase study reported from New York State Psychiatric Institute, New York. |
|---|---|
| Item Description: | 1043-3155 2166-6482 10.15844/pedneurbriefs-20-7-7 |